Abcam expands custom services capabilities with the acquisition of Calico Biolabs
London and Cambridge, UK, 28 January 2019: Abcam plc, a global innovator in life science reagents and tools, is pleased to announce its acquisition of Calico Biolabs, a developer of custom high-quality recombinant rabbit monoclonal antibodies for diagnostics and pharmaceutical company partners. Joyce Young, Vice President of Custom Services, Abcam commented:“This acquisition strategically expands our leadership... Read more